Thanks for requesting this resource from US-Rx Care.
Check your email for access to your download soon. In the meantime, feel free to explore additional resources below.
With over 30 years of experience managing pharmacy risk for health plans and self-insured employers, plus our contractual obligation to fiduciary standards and transparency, US-Rx Care is unlike any other entity in the pharmacy benefit industry when it comes to delivering cost containment without sacrificing quality of care. Explore our solutions to learn more about our innovative model:
Access Our Full Resource Library
Downloadable Resources
National Alliance Playbook:
Addressing Pharmacy Benefit Management Misalignment.
White Paper:
Pharmacy Risk Management with a Fiduciary Mindset.
White Paper:
Critically important strategies to reduce specialty spend.
Industry Brief:
CAA Quick Guide for self-insured employers.
White Paper:
A self-insured employers’ guide to Navigating CAA Compliance.
Industry Insights:
Busting common myths related to benefits management.
White Paper:
2024 employer action plan for overcoming PBM challenges.
White Paper:
The Problem With PBM Rebate Guarantees
Explore Case Studies
Case Study:
How US-Rx care helped a multi-state hospital group save more than $10 million on annual drug costs.
Case Study:
How US-Rx Care helped a multi-district educational nonprofit save millions in pharmacy benefits costs.
Case Study:
How US-Rx Care saved a group plan $3.6MM a year in drug costs.
Case Study:
How US-Rx Care saved a grocery store chain $3.1MM a year.
Case Study:
How US-Rx Care Saved $58,669 a Year in Drug Costs for a Group Plan.
Case Study:
How US-Rx Care Saved $991,118 per year in drug costs for a group plan.
Case Study:
Securing a 5-figure savings with one psoriasis medication.
Explore Our Blog
Health Plans Covering Fewer Drugs, Imposing More Restrictions
As prescription drug costs continue growing and pricey new pharmaceuticals add to health plans'...
Study Predicts 8% Group Health Plan Cost Increase for 2025
A new study predicts that group health insurance costs will jump 8% in 2025, on par with what American employers have experienced this year and in 2023.
The higher rates reflect the costs borne by health insurers, which are seeing more claims for care that was postponed during the COVID-19 pandemic and a steady rise in the cost of pharmaceuticals as more innovative and effective drugs come to market, according to the study. There are also a few new cost drivers, which are counterbalanced by the potential for savings thanks to some new developments.
Addictions Are Rising Among Workers; What Employers Can Do
According to a study by the Substance Abuse and Mental Health Services Administration, 10% of...